These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 39362213)
1. Adherence to Hygiene Protocols and Doxycycline Therapy in Ameliorating Lymphatic Filariasis Morbidity in an Endemic Area Post-Interruption of Disease Transmission in Ghana. Debrah LB; Klarmann-Schulz U; Osei-Mensah J; Kuehlwein JM; Mubarik Y; Nadal J; Ayisi-Boateng NK; Ricchiuto A; Opoku VS; Sullivan SM; Mensah DA; Horton J; Rahamani AA; Budge PJ; Gbedema S; Korir PJ; Opoku J; Pfarr K; Kontoh DB; Kellings A; Gyasi C; Obeng MA; Gruetzmacher B; Fordjour FA; Kroidl I; Horn S; Kuutiero EK; Wauschkuhn C; Ngenya A; Mackenzie C; Wanji S; Kalinga A; Ottesen EA; Hoerauf A; Debrah AY Am J Trop Med Hyg; 2024 Oct; 111(4_Suppl):66-82. PubMed ID: 39362213 [TBL] [Abstract][Full Text] [Related]
2. LEDoxy-SL: A Placebo-Controlled, Double-Blind, Randomized, 24-Month Trial of Six Weeks of Daily Doxycycline Plus Hygiene-Based Essential Care for Reducing Progression of Filarial Lymphedema in Sri Lanka. Yahathugoda TC; De Silva NL; Ruben J; Gunawardena S; Weerasooriya MV; Horton J; Budge P; Ottesen E; Sullivan SM; Stephens M; Shen J; Klarmann-Schulz U; Hoerauf A; Shott JP; Mackenzie C Am J Trop Med Hyg; 2024 Oct; 111(4_Suppl):52-65. PubMed ID: 39043165 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of Intensified Hygiene Measures with or without the Addition of Doxycycline in the Management of Filarial Lymphedema: A Randomized Double-Blind, Placebo-Controlled Clinical Trial in Tanzania. Ngenya A; Klarmann-Schulz U; John W; Korir PJ; Kamugisha M; Nadal J; Moshi D; Ricchiuto A; Oriyo N; Sullivan SM; Laizer R; Horton J; Demitrius M; Feichtner A; Marandu TF; Mgaya Y; Kellings A; Kroidl I; Ogondiek J; Kuehlwein JM; Masagati L; Mackenzie C; Mosoba M; Horn S; Kagya K; Wanji S; Mandara W; Debrah LB; Ottesen EA; Debrah AY; Mwingira U; Hoerauf A; Kalinga A Am J Trop Med Hyg; 2024 Oct; 111(4_Suppl):33-51. PubMed ID: 39191236 [TBL] [Abstract][Full Text] [Related]
4. Effect of Adding a Six-Week Course of Doxycycline to Intensive Hygiene-Based Care for Improving Lymphedema in a Rural Setting of Mali: A Double-Blind, Randomized Controlled 24-Month Trial. Coulibaly YI; Diabate AF; Sangare M; Thera SO; Dolo H; Doumbia SS; Coulibaly SY; Diarra A; Diarra L; Tanapo D; Coulibaly ME; Soumaoro L; Diallo AA; Zeguime A; Sanogo Y; Berthe A; Konipo FDN; Mackenzie C; Stephens M; Shott JP; Norman J; Klarmann-Schulz U; Hoerauf A; Majewski A; Horton J; Sullivan S; Ottesen EA; Nutman TB Am J Trop Med Hyg; 2024 Oct; 111(4_Suppl):22-32. PubMed ID: 39013374 [TBL] [Abstract][Full Text] [Related]
5. Doxycycline improves filarial lymphedema independent of active filarial infection: a randomized controlled trial. Mand S; Debrah AY; Klarmann U; Batsa L; Marfo-Debrekyei Y; Kwarteng A; Specht S; Belda-Domene A; Fimmers R; Taylor M; Adjei O; Hoerauf A Clin Infect Dis; 2012 Sep; 55(5):621-30. PubMed ID: 22610930 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Adding 6 Weeks of Doxycycline to the Essential Package of Care to Treat Filarial Lymphedema: A Double-Blind, Randomized, Controlled Trial in Southern India. Krishnasastry S; Ashok A; Devidas A; Sullivan S; Stephens M; Norman J; Paljug E; Deathe A; Majewski A; Horton J; Shott JP; Klarmann-Schulz U; Hoerauf A; Ottesen E; Mackenzie CD Am J Trop Med Hyg; 2024 Oct; 111(4_Suppl):83-93. PubMed ID: 39362214 [TBL] [Abstract][Full Text] [Related]
7. Doxycycline reduces plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasis. Debrah AY; Mand S; Specht S; Marfo-Debrekyei Y; Batsa L; Pfarr K; Larbi J; Lawson B; Taylor M; Adjei O; Hoerauf A PLoS Pathog; 2006 Sep; 2(9):e92. PubMed ID: 17044733 [TBL] [Abstract][Full Text] [Related]
8. Potential factors influencing lymphatic filariasis transmission in "hotspot" and "control" areas in Ghana: the importance of vectors. Pi-Bansa S; Osei JHN; Frempong KK; Elhassan E; Akuoko OK; Agyemang D; Ahorlu C; Appawu MA; Koudou BG; Wilson MD; de Souza DK; Dadzie SK; Utzinger J; Boakye DA Infect Dis Poverty; 2019 Feb; 8(1):9. PubMed ID: 30717788 [TBL] [Abstract][Full Text] [Related]
9. Persistent 'hotspots' of lymphatic filariasis microfilaraemia despite 14 years of mass drug administration in Ghana. Biritwum NK; Yikpotey P; Marfo BK; Odoom S; Mensah EO; Asiedu O; Alomatu B; Hervie ET; Yeboah A; Ade S; Hinderaker SG; Reid A; Takarinda KC; Koudou B; Koroma JB Trans R Soc Trop Med Hyg; 2016 Dec; 110(12):690-695. PubMed ID: 28938053 [TBL] [Abstract][Full Text] [Related]
10. Improving Coverage and Compliance in Mass Drug Administration for the Elimination of LF in Two 'Endgame' Districts in Indonesia Using Micronarrative Surveys. Krentel A; Damayanti R; Titaley CR; Suharno N; Bradley M; Lynam T PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005027. PubMed ID: 27812107 [TBL] [Abstract][Full Text] [Related]
11. Community-based trial of annual versus biannual single-dose ivermectin plus albendazole against Wuchereria bancrofti infection in human and mosquito populations: study protocol for a cluster randomised controlled trial. de Souza DK; Ahorlu CS; Adu-Amankwah S; Otchere J; Mensah SK; Larbi IA; Mensah GE; Biritwum NK; Boakye DA Trials; 2017 Oct; 18(1):448. PubMed ID: 28969715 [TBL] [Abstract][Full Text] [Related]
12. The design and development of a multicentric protocol to investigate the impact of adjunctive doxycycline on the management of peripheral lymphoedema caused by lymphatic filariasis and podoconiosis. Horton J; Klarmann-Schulz U; Stephens M; Budge PJ; Coulibaly Y; Debrah A; Debrah LB; Krishnasastry S; Mwingira U; Ngenya A; Wanji S; Weerasooriya M; Yahathugoda C; Kroidl I; Deathe D; Majewski A; Sullivan S; Mackenzie C; Nutman TB; Shott JP; Weil G; Ottesen E; Hoerauf A Parasit Vectors; 2020 Mar; 13(1):155. PubMed ID: 32228663 [TBL] [Abstract][Full Text] [Related]
13. Review of MDA registers for Lymphatic Filariasis: Findings, and potential uses in addressing the endgame elimination challenges. de Souza DK; Gass K; Otchere J; Htet YM; Asiedu O; Marfo B; Biritwum NK; Boakye DA; Ahorlu CS PLoS Negl Trop Dis; 2020 May; 14(5):e0008306. PubMed ID: 32407319 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of ivermectin and albendazole combination in suppressing transmission of lymphatic filariasis following mass administration in Tanzania: a prospective cohort study. Fimbo AM; Mnkugwe RH; Mlugu EM; Kunambi PP; Malishee A; Minzi OMS; Kamuhabwa AAR; Aklillu E Infect Dis Poverty; 2024 Jun; 13(1):44. PubMed ID: 38867265 [TBL] [Abstract][Full Text] [Related]
15. How Thailand eliminated lymphatic filariasis as a public health problem. Rojanapanus S; Toothong T; Boondej P; Thammapalo S; Khuanyoung N; Santabutr W; Prempree P; Gopinath D; Ramaiah KD Infect Dis Poverty; 2019 May; 8(1):38. PubMed ID: 31130143 [TBL] [Abstract][Full Text] [Related]
16. Community-directed treatment: the way forward to eliminating lymphatic filariasis as a public-health problem in Ghana. Gyapong M; Gyapong JO; Owusu-Banahene G Ann Trop Med Parasitol; 2001 Jan; 95(1):77-86. PubMed ID: 11235557 [TBL] [Abstract][Full Text] [Related]
17. Exploring factors affecting quality implementation of lymphatic filariasis mass drug administration in Bole and Central Gonja Districts in Northern Ghana. Manyeh AK; Ibisomi L; Ramaswamy R; Baiden F; Chirwa T PLoS Negl Trop Dis; 2020 Aug; 14(8):e0007009. PubMed ID: 32804967 [TBL] [Abstract][Full Text] [Related]
18. Lymphatic filariasis control in Tanzania: infection, disease perceptions and drug uptake patterns in an endemic community after multiple rounds of mass drug administration. Derua YA; Kisinza WN; Simonsen PE Parasit Vectors; 2018 Jul; 11(1):429. PubMed ID: 30029675 [TBL] [Abstract][Full Text] [Related]
19. A randomized double-blind placebo-controlled field trial of ivermectin and albendazole alone and in combination for the treatment of lymphatic filariasis in Ghana. Dunyo SK; Nkrumah FK; Simonsen PE Trans R Soc Trop Med Hyg; 2000; 94(2):205-11. PubMed ID: 10897370 [TBL] [Abstract][Full Text] [Related]
20. Reduction in acute filariasis morbidity during a mass drug administration trial to eliminate lymphatic filariasis in Papua New Guinea. Tisch DJ; Alexander ND; Kiniboro B; Dagoro H; Siba PM; Bockarie MJ; Alpers MP; Kazura JW PLoS Negl Trop Dis; 2011 Jul; 5(7):e1241. PubMed ID: 21765964 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]